Our Team

Each Partner brings extensive industry knowledge, unrivaled relationships and substantial deal experience, resulting in a team of the industry's most sought after advisors

Andrew S. Rymer

Andrew Rymer is a member of Centerview’s healthcare investment banking team.   He brings nearly 20 years of experience, advising companies on a variety of strategic matters.

Mr. Rymer has established himself as one the leading healthcare advisors, having worked on some of the industry’s largest and most important transactions.  These include: Pfizer’s $68 billion acquisition of Wyeth; Johnson & Johnson’s $21bn acquisition of Synthes; Pfizer’s $14bn acquisition of Medivation and $5.2bn acquisition of Anacor; athenahealth’s $5.7bn sale to Veritas Capital and Evergreen Coast Capital; Merck’s €3.25 billion acquisition of Antelliq Group; Endocyte’s $2.1bn sale to Novartis; Catalent’s $1.2bn acquisition of Paragon Bioservices; Micromet’s $1.2 billion sale to Amgen; NeuroDerm’s $1.1bn sale to Mitsubishi Tanabe; inVentiv’s $1.1 billion sale to TH Lee; Novartis’s $1bn sale of its Sandoz US dermatology and generics business to Aurobindo; Nightstar Therapeutics’ $877mm sale to Biogen; Pfizer’s joint venture with GlaxoSmithKline to create the world’s leading consumer healthcare company; Merck’s worldwide strategic collaboration with Eisai regarding Lenvima; Phillip-Medisize’s sale to Golden Gate Capital; and US Renal’s sale to Leonard Green.

Additionally, Mr. Rymer has executed numerous financing transactions and advisory assignments for a diverse group of industry leaders including Pfizer, Johnson & Johnson, Eli Lilly, Aetna, Wellchoice, Horizon Blue Cross Blue Shield and many of the largest financial sponsors.

Prior to joining Centerview, Mr. Rymer spent 10 years at Goldman Sachs, most recently as a Managing Director with responsibility for the firm’s Healthcare M&A activities.  While at Goldman Sachs, he was asked by the firm’s CEO and President to serve as Head of Client Strategy for 18 months in order to help enhance effectiveness across Goldman’s client footprint.  Mr. Rymer began his career as an investment banking analyst at Donaldson, Lufkin & Jenrette and worked at Credit Suisse upon its acquisition of DLJ.

Mr. Rymer received a B.A., cum laude and with Honors, from Dartmouth College. Mr. Rymer lives in New York City with his wife and three children.
Centerview Partners takes a “One Firm” approach to deliver unmatched intellectual capital and integrity to all of our clients. We have industry-leading expertise in:

Centerview is honored to partner with leading charitable organizations in active support of our charities:

  • Arts Connection
  • NY Cares
  • Bottomless Closet
Pope Resources
Announced: Q1 2020
Value: $656 million
Status: Pending

Exclusive financial advisor to Pope Resources on its sale to Rayonier Inc.
View All
New York

Centerview Partners LLC
31 West 52nd Street
22nd Floor
New York, New York 10019

(212) 380-2650 | Tel
(212) 380-2651 | Fax

Centerview Partners UK LLP
100 Pall Mall
3rd Floor
London SW1Y 5NQ,

02074099700 | Tel
02074099704 | Fax
San Francisco

Centerview Partners LLC
555 California Street
Suite 4300
San Francisco, CA 94104

(415) 400-0900 | Tel
(415) 400-0901 | Fax
Los Angeles

Centerview Partners LLC
1999 Avenue of the Stars
Suite 3030
Los Angeles, CA 90067

(424) 230-5950 | Tel
(424) 230-5951 | Fax
Palo Alto

Centerview Partners LLC
600 Ramona St.
Suite 300
Palo Alto, California 94301

(650) 822-5800 | Tel
(650) 822-5801 | Fax

Copyright © 2008 - 2020 Centerview Partners Holdings LP. All Rights Reserved. | Privacy and Other Notices

Centerview Partners LLC, member SIPC